The median progression free survival, 1.5 years for CHOP versus not reached for R-CHOP, and the median overall survival (OS) was 3.1 years for CHOP and not ...

Data suggest that 5-year survival rates in diffuse large cell lymphoma are higher for white persons than they are for people of African descent, ...

It may be localized (in one spot) or generalized (spread throughout the body). Despite being an aggressive lymphoma, DLBCL is considered potentially curable.

Treatment for diffuse large B-cell lymphoma (DLBCL)

Most people with early-stage DLBCL (stage 1 or stage 2) are treated with a short course of chemotherapy or chemo-immunotherapy (chemotherapy given with antibody ...

Prognosis and survival rates ... Two-thirds of people with DLBCL who are treated can be cured. However, if it's left untreated, it can lead to death. Most people ...

Diffuse large B cell lymphoma (DLBCL) is the commonest subtype of non-Hodgkin's lymphoma accounting for approximately 30–50 % of cases [1].

Below are the 5-year relative survival rates for two common types of NHL - diffuse large B-cell lymphoma and follicular lymphoma - based on ...

Diffuse large B cell lymphoma (DLBCL) is the most common histologic subtype of non-Hodgkin lymphoma (NHL), accounting for approximately 25 ...